Febrile neutropenia remains an important complication of treatment with cytotoxic
chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this …

Over the past several decades, there has been substantial progress in the management of
patients with febrile neutropenia. However, the ever‐changing patterns of infection, ecology …

Fever is the principle sign of infection in neutropenic patient and frequently may be the only
evidence of infection. The pattern of fever in neutropenia is non-specific and not …

Summary Between May 1988 and November 1989, 68 consecutive febrile courses
supervening after polychemotherapy for lymphoma outpatients (median age 50 years) were …

Purpose. Febrile neutropenia (FN) is a common, costly, and potentially fatal complication in
oncology. While FN in the inpatient setting has been extensively studied, only one study has …

Febrile neutropenia is one of the most serious complications in patients with haematological
malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic …

Background Among patients with fever and neutropenia during cancer chemotherapy who
have a low risk of complications, oral administration of empirical broad-spectrum antibiotics …

Febrile neutropenia (FN) continues to represent a major cause of morbidity, mortality, and
cost in patients receiving cancer chemotherapy. The reported rates of FN vary considerably …

INTRODUCTION The management of infections in cancer patients has evolved both
conceptually and practically over the past twenty years. The advent of cytotoxic therapy …

Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA)
guideline on outpatient management of fever and neutropenia in patients with cancer …